266 related articles for article (PubMed ID: 33049155)
1. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics.
van Hoogdalem MW; McPhail BT; Hahn D; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):87-103. PubMed ID: 33049155
[TBL] [Abstract][Full Text] [Related]
2. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.
Tang F; Ng CM; Bada HS; Leggas M
Clin Transl Sci; 2021 Jul; 14(4):1231-1249. PubMed ID: 33650314
[TBL] [Abstract][Full Text] [Related]
4. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
5. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T
Clin Pharmacol Ther; 2022 Feb; 111(2):496-508. PubMed ID: 34679189
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
McPherson C
Neonatal Netw; 2016; 35(5):314-20. PubMed ID: 27636696
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
8. Neonatal abstinence syndrome.
Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
[TBL] [Abstract][Full Text] [Related]
9. Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.
Devlin LA; Young LW; Kraft WK; Wachman EM; Czynski A; Merhar SL; Winhusen T; Jones HE; Poindexter BB; Wakschlag LS; Salisbury AL; Matthews AG; Davis JM
J Perinatol; 2022 Mar; 42(3):300-306. PubMed ID: 34556799
[TBL] [Abstract][Full Text] [Related]
10. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
[No Abstract] [Full Text] [Related]
11. Neonatal opioid withdrawal syndrome.
Sutter MB; Leeman L; Hsi A
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
[TBL] [Abstract][Full Text] [Related]
12. Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome.
Townsel C; Covault JM; Hussain N; Oncken C; Nold C; Campbell WA
J Matern Fetal Neonatal Med; 2021 Mar; 34(5):670-676. PubMed ID: 31092079
[No Abstract] [Full Text] [Related]
13. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
Jones HE; Kraft WK
Clin Perinatol; 2019 Jun; 46(2):349-366. PubMed ID: 31010564
[TBL] [Abstract][Full Text] [Related]
14. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
Merhar SL; Ounpraseuth S; Devlin LA; Poindexter BB; Young LW; Berkey SD; Crowley M; Czynski AJ; Kiefer AS; Whalen BL; Das A; Fuller JF; Higgins RD; Thombre V; Lester BM; Smith PB; Newman S; Sánchez PJ; Smith MC; Simon AE;
Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632932
[TBL] [Abstract][Full Text] [Related]
15. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapies for the treatment of neonatal abstinence syndrome.
Frazier LM; Bobby LE; Gawronski KM
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):987-995. PubMed ID: 32146833
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
Ghazanfarpour M; Najafi MN; Roozbeh N; Mashhadi ME; Keramat-Roudi A; Mégarbane B; Tsatsakis A; Moghaddam MMM; Rezaee R
Daru; 2019 Jun; 27(1):423-431. PubMed ID: 31093953
[TBL] [Abstract][Full Text] [Related]
18. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M
Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504
[TBL] [Abstract][Full Text] [Related]
19. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
[TBL] [Abstract][Full Text] [Related]
20. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
